RE:RE:New Year's 2020 will be good, but 2022 will be special!Conservative is one thing, out of touch with reality is quite another. A buck is not a realistic guess for the sp of a company with an FDA approved treatment for bladder cancer. Do just a little research.
newdaydawning wrote: I'm a realist. I'll take 30 cents at year end 2019. Two years later, with exceptional results from PH2 NMIBC, we should be worth at least a buck or more. My call is probably as it conservative as it gets. If you lower your expectations to the lowest possible scenario, you will be pleasantly surprised when TLT greatly outperforms in the clinic.